Cor Vasa 2008, 50(12):K254-255

Kardiovaskulární sledování dětí a mladistvých se srdečním onemocněním při léčbě stimulancii

Pavel Jerie

Published: December 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Jerie P. Kardiovaskulární sledování dětí a mladistvých se srdečním onemocněním při léčbě stimulancii. Cor Vasa. 2008;50(12):K254.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Vetter VL, Elia J, Erickson Ch, et al. Cardiovascular monitoring of children and adolescents with heart disease receiving stimulant drugs. A scientific statement from the American Heart Association Council on cardiovascular disease i the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing. Circulation 2008;117:2407-23. Go to original source... Go to PubMed...
    2. Biedermannn J, Thisted RA, Greenhill LL, et al. Estimation of the association between desipramine and the risk for sudden death in 5- to 14-year old children. J Clin Psychiatry 1995;56:87-93.
    3. Biedermann J, Gastfriend D, Jellinek MS, et al. Cardiovascular effects of desipramine in children and adolescent with attention deficite disorder. J Pediatr 1985; 106:1017-20. Go to original source... Go to PubMed...
    4. Corrado D, Basso C, Pavel A, et al. Screening of hypertrophic cardiomyopathy in young athletes. N Engl J Med 1998;339:364-9. Go to original source... Go to PubMed...
    5. Goulene K, Stramba-Badiale M, Crozzi L, et al. Neonatal electrocardiographic screening of genetic arrhythmogenic disorders and congenital cardiovascular diseases; prospective data from 31 000 infants. Eur Heart J 2005; 26 (Suppl):214 [Abstract]. Go to original source... Go to PubMed...
    6. International Olympic Committee Medical Commission, Intern. Olymp. Committee: Sudden Cardiovascular Death in Sport. Lausanne recommendation. Adopted December 10, 2004. Available at: htth://multimedia. olympic.org/pdf/en_report_886.pdf. Accessed September 7, 2007.
    7. Jerie P, Vít P. Význam elektrokardiografie ve vývoji nových léků - prodloužení intervalu QT jako ukazatel nežádoucích účinků. Vnitř Lék 2002;48/S1:114-9. Go to PubMed...

    Return to the content


    Cor et Vasa

    You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

    I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.


    No
    Yes